Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit. Research examines telehealth, healthcare disparities, as well as impacts on interventional cardiology, patient-centered care.
News | Coronavirus (COVID-19) | October 14, 2020
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit
October 14, 2020 — American College of Cardiology (ACC) Quality Summit Virtual Oct. 8-9, 2020, featured several poster...
read more
Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

News | TCT | October 14, 2020
ACC and CRF Create the Martin B. Leon Center for Cardiovascular Transformation
October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are...
read more
COVID-19 Positive STEMI Patients Have Higher Mortality, First data presented at #TCT2020 on COVID heart attack patients.

Getty Images

News | Coronavirus (COVID-19) | October 14, 2020
COVID-19 Positive STEMI Patients Have Higher Mortality 
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction...
read more
Videos | Coronavirus (COVID-19) | October 06, 2020
VIDEO: ECMO Support Effective in Sickest COVID-19 Patients
Ryan Barbaro, M.D., clinical assistant professor, pediatric critical care medicine, University of Michigan, and chair...
read more
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum...
read more
Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and very low survival rates. Getty Images

Feature | Coronavirus (COVID-19) | October 02, 2020
Cardiac Arrest With Poor Survival Common in Sickest COVID-19 Patients
October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily...
read more
Videos | Coronavirus (COVID-19) | September 29, 2020
VIDEO: Overview of Multisystem Inflammatory Syndrome in Children (MIS-C) in COVID-19 Exposed Children
Deepika Thacker, M.D., a pediatric cardiologist with Nemours Children’s Health System, Wilmington, Del., helped...
read more

An ECMO procedure at Tufts Medical Center in Boston. The FDA cleared the use of ECMO support for COVID-19 patients in April 2020. A new review of patients treated with ECMO showed it had positive outcomes in the most severe COVID-19 patients. Photo by Dave Fornell

News | Coronavirus (COVID-19) | September 29, 2020
ECMO Support Found Effective in Sickest of COVID-19 Patients
September 29, 2020 –  Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging...
read more
hort-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC). #COVID19 #SARSCoV2 #hydroxychloroquine
News | Coronavirus (COVID-19) | September 25, 2020
Short-term Hydroxychloroquine Use in COVID-19 Patients Does Not Cause Lethal Arrhythmias if Screened
September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients...
read more
SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.

SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.

News | Coronavirus (COVID-19) | September 24, 2020
Statins May Reduce COVID-19 Severity
September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health...
read more
COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events
September 17, 2020 — Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of...
read more
Naples Community Hospital Director of Cardiac Imaging Bill Shirkey showing a point-of-care echocardiogram of a COVID-19 patient he imaged with a GE Healthcare Vscan device bedside in an isolation room. Use of a small handheld device greatly speeds disinfection after the exam and does not require moving a larger cart-based ultrasound system into a room, which may require moving furniture and add exposure time in the room.

Naples Community Hospital Director of Cardiac Imaging Bill Shirkey showing a point-of-care echocardiogram of a COVID-19 patient he imaged with a GE Healthcare Vscan device bedside in an isolation room. Use of a small handheld device greatly speeds disinfection after the exam and does not require moving a larger cart-based ultrasound system into a room, which may require moving furniture and add exposure time in the room.

Feature | Coronavirus (COVID-19) | September 15, 2020
Handheld Ultrasound Helps to Monitor COVID-19 Patients With Cardiac Conditions
September 15, 2020 — The world is facing a global pandemic with unknown implications, but is now well known COVID-19 (...
read more
Videos | Coronavirus (COVID-19) | September 15, 2020
VIDEO: Example of a Multisystem Inflammatory Syndrome in Children (MIS-C) Pediatric Echocardiogram
Case is a 6-month-old infant boy admitted to hospital due to respiratory distress then worsened by a pericardial...
read more
Exantham on abdomen and back of a pediatric patient at Nemours Children’s Health System in Delaware who presented with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the United States.

Exantham on abdomen and back of a pediatric patient at Nemours Children’s Health System in Delaware who presented with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. Find more images

News | Coronavirus (COVID-19) | September 14, 2020
Case Study Describes One of the First U.S. Cases of MIS-C
September 14, 2020 – At the height of the COVID-19 (SAR-CoV-2) pandemic in April, a 14-year-old boy was admitted to the...
read more
The NIH is heading three studies looking at various blood thinners and anticoagulants to treat COVID-19 patients with VTE.
News | Coronavirus (COVID-19) | September 11, 2020
NIH Trials Evaluate Various Blood Thinners to Treat COVID-19
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials...
read more
© Copyright Wainscot Media. All Rights Reserved.